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Effects of vitamin E and pyrroloquinoline quinone on peripheral nerve regeneration were studied using a
rat sciatic nerve transection model. Ninety male healthy White Wistar rats were divided into three
experimental groups (n ¼ 15), randomly: Sham-operation (SHAM), transected control (TC), chitosan
conduit (Chit) and three treatment groups (Vit E, PQQ and PQQ þ Vit E). In SHAM group after anesthesia,
left sciatic nerve was exposed through a gluteal muscle incision and after homeostasis muscle was su-
tured. In Chit group left sciatic nerve was exposed the same way and transected proximal to tibio-
peroneal bifurcation leaving a 10-mm gap. Proximal and distal stumps were each inserted into a chi-
tosan tube. In treatment groups the tube was implanted the same way and ﬁlled with Vit E, PQQ and
PQQ þ Vit E. Each group was subdivided into three subgroups of six animals each and were studied 4, 8,
12 weeks after surgery. Functional and electrophysiological studies, and gastrocnemius muscle mass
measurement conﬁrmed faster and better recovery of regenerated axons in Vit E þ PQQ combination
compared to Vit E or PQQ solely (P < 0.05). Morphometric indices of regenerated ﬁbers showed number
and diameter of the myelinated ﬁbers in PQQ þ Vit E was signiﬁcantly higher than in other treatment
groups. In immunohistochemistry, location of reactions to S-100 in PQQ þ Vit E was clearly more positive
than in other treatment groups. Response to PQQ þ Vit E treatment demonstrates that it inﬂuences and
improves functional recovery of peripheral nerve regeneration.
 2013 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Peripheral nerve injuries are common in clinical practices,1 and
occasionally may result in an acquired life-long disability.2 Grafting
is usually suggested for peripheral nerve gaps which are not suit-
able for neurorrhaphy. The grafts can be autologous, heterologous
(allografts) or synthetic biomaterials. Autologous nerve graft is
widely accepted, however, it has several disadvantages and donor
graft nerves are limited3; Therefore, various synthetic materials or
biomaterials including degradable and non-degradable ones have
been developed for nerve bridging.4e7
Recent studies show a beneﬁt of using chitosan as a scaffold in
promoting wound healing, cartilage repair and nerve regenera-
tion.8e10 Our previous study showed Chitosan as a suitableiences, Faculty of Veterinary
53 1177, Iran. Tel.: þ98 441
ciates Ltd. Published by Elsevier Ltfunctional conduit for promoting of sciatic nerve regeneration in
rat.11 Alongside, this temporary guidance tube does not act as a
foreign body in situ, also does not affect nerve functional recov-
ery,12 and no needs for second surgery removal.
Recent studies are focused on local application of promoting
components such as stromal vascular fraction, stem cells, antioxi-
dants, and biologic agents for peripheral nerve regeneration.13e20
Vitamin E is a primary liposoluble antioxidant. It plays a role in
scavenging free oxygen radicals and in stabilizing the cell mem-
branes.21 Degenerative changes in central and peripheral nervous
systems have been reported in vitamin E deﬁciency. Reportedly,
nerve regeneration is decreased during peripheral nerve injury in
vitamin E-deﬁcient rats.22
Pyrroloquinoline quinone (PQQ) is a low molecular weight
redox cofactor that acts as an antioxidant against lipid peroxidation
to prevent cell injury. It has been reported to stimulate cell prolif-
eration and to enhance nerve growth factor (NGF) synthesis and
secretion in certain cell lines.23,24d. All rights reserved.
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of topically administered Vit E, PQQ and their combination on pe-
ripheral nerve regeneration and reinnervation along chitosan
conduit repair in rat sciatic nerve transection model. Assessment
of the nerve regeneration was based on functional (walking
track analysis), electrophysiological measurement, muscle mass
measurement, histomorphometric, and immunohistochemical
(Schwann cell detection by S-100 expression) criteria at 4, 8, and 12
weeks after surgery.
2. Materials and methods
2.1. Experimental design
Ninety male White Wistar rats weighing approximately 200e
240 g. were randomly divided into six experimental groups
(n ¼ 15). These groups included sham-operation (Sham group),
transected control (TC group), chitosan conduit (Chit group), and
three treatment groups. In Chit group, the conduit ﬁlled by 20 ml
soybean oil (sigma C7381 SigmaeAldrich Germany); and in treat-
ment groups the implanted chitosan ﬁlled by 20 ml Vit E (20 mg/kg
Vitamin E, DL-all-rac-a-Tocopherol, T3251 Germany) (Chit/Vit E
group); 20 ml PQQ (0.03 mmol/lit Pyrroloquinoline quinone,
SigmaeAldrich D7783 China) (Chit/PQQ group), and a combination
of 10 ml Vit E þ 10 ml PQQ (Chit/Vit E-PQQ combination).
Each group was further subdivided into three subgroups of
ﬁve animals each. Two weeks before and during the entire exper-
iment, the animals were housed in individual plastic cages
(50 40 20 cm) with an ambient temperature of 23 3 C, stable
air humidity, and a natural day/night cycle. The animals were
handled on a regular daily basis for 2 weeks prior to the study in
order to acclimatize them with testing area and experiment. The
rats had free access to standard rodent laboratory food and tap
water. All procedures were carried out in accordance with the
guidelines of the Ethics Committee,25 and the University Research
Council approved all experiment.
2.2. Preparation of chitosan conduit
A home-made chitosan conduit was constructed based on
Qiang Ao et al., 2011. Brieﬂy, chitosan solution was prepared by
dissolving medium molecular weight, crab shell chitosan
(w400 kDa, 85% deacetylated) (Fluka, SigmaeAldrich St. Louis,
MO, USA) in an aqueous solution (1% v/v) of glacial acetic acid
(Merck, Darmstadt, Germany) to a concentration of 2% (w/v)
while stirring on a magnetic stirrer-hot plate. The solution was
stirred with low heat (at 50 C) for three hours. The resultant
chitosan was ﬁltered through a Whatman No. 3 ﬁlter paper.
Again, to remove any un-dissolved particles the solution ﬁltrated
through vacuum ﬁltration. To overcome the undesired fragile
character, glycerol (Sigma Chemical Co., St. Louis, MO, USA) was
added as 30% (w/w) of the total solid weight in solution.26 Chi-
tosan conduit was made by gentle injection of the prepared so-
lution into a home-made mold.
2.3. Grafting procedure
Animals were anesthetized by intraperitoneal administration
with a combination of ketamine hydrochloride 5%, 90 mg/kg
(Ketaset 5%; Alfasan, Woerden, The Netherlands) and xylazine hy-
drochloride 2%, 5 mg/kg (Rompun 2%, Bayer, Leverkusen, Germany).
Following surgical preparation, in the sham-operation group the left
sciatic nerve was exposed through a gluteal muscle incision and
after sciatic nerve exposure the splitted muscle was sutured with 4/
0 Vicryl (Ethicon, Norderstedt) and the skin with 3/0 nylon (Daﬁlon,B/Braun, Germany) was closed. In TC group, the left sciatic nerve was
exposed the sameway and transected proximal to the tibio-peroneal
bifurcationwhere a 8 mm segment was excised, leaving a gap about
10 mm due to retraction of the nerve ends. The proximal and distal
stumpswere ﬁxed in the adjacentmusclewith 10/0 nylon epineurial
suture and no conduit was placed between the stumps. In Chit
group, following nerve transection the proximal and distal nerve
ends were inserted 2 mm into the conduit and were sutured with
two 10/0 nylon epineurial sutures. In treatment groups, following
chitosan conduit implantation the conduit were ﬁlled as mentioned
before. The ends of conduit were sealed using sterile Vaseline to
avoid leakage in all groups. Then, the animals were housed in groups
of ﬁve per cage under the same condition mentioned above.
The animals of each group were anesthetized by intraperitoneal
administration of ketamineexylazine (see above) and were
perfused via left cardiac ventricle with a ﬁxative containing 2%
paraformaldehyde and 1% glutaraldehyde buffer (pH ¼ 7.4) at 4
(n ¼ 5), 8 (n ¼ 5) and 12 weeks (n ¼ 5) after surgery.
2.4. Functional assessment of nerve regeneration
Walking track analysis was performed 4, 8 and 12 weeks after
surgery based on Bain et al.27 The lengths of the third toe to its heel
(PL), the ﬁrst to the ﬁfth toe (TS), and the second toe to the fourth
toe (IT) were measured on the experimental side (E) and the
contralateral normal side (N) in each rat. The Sciatic Function Index
(SFI) in each animal was calculated by the following formula:
SFI ¼ 38.3  (EPL  NPL)/NPL þ 109.5  (ETS  NTS)/
NTS þ 13.3  (EIT  NIT)/NIT  8.8. In general, the SFI oscillates
around 0 for normal nerve function, whereas around 100 SFI rep-
resents totaldysfunction. TheSFIwasassessedbasedontheNCgroup
and the normal level was considered as 0. The SFI was a negative
value and a higher SFI meant the better function of the sciatic nerve.
2.5. Electrophysiological measurement
After 12 weeks, fallowing the track test, all animals were sub-
jected to electrophysiological studies using Nacro bio system 320e
3760 A trace 80 (USA). Under general anesthesia (see above), the left
sciatic nerve was re-exposed by incision of the skin at the previous
surgical site. Single electrical pulses (at supra maximal intensity)
were delivered via bipolar electrodes placed in turn at the proximal
and distal trunk of the regenerated nerve and electromyography
(EMG) was recorded by inserting an electrode into the belly of
gastrocnemius muscle. The latency and the amplitude of EMGwere
obtained. Also, the difference in latency of EMG was measured, and
the distance between the proximal and distal sites of stimulation
was measured to calculate the conduction velocity across the re-
generated nerve. On the contralateral, right intact side of each an-
imal, similar measurements were made for the determination of
conduction velocity. The conduction velocity of the bridged nerve
was expressed as a percentage of that on the intact side of each
animal to cancel off variations between animals (%CVR).28
The recovery index of EMG amplitude in all groups calculated
based on Suzuki et al. by the formula: Recovery index ¼ Peak
amplitude of the operated side/Peak amplitude of the intact side.29
2.6. Muscle mass measurement
Recovery assessment was also indexed using the weight ratio of
the gastrocnemius muscles 12 weeks after surgery. Immediately
after sacriﬁcing of animals, gastrocnemius muscles were dissected
and harvested carefully from intact and injured sides and weighed
while still wet, using an electronic balance. All measurements were
made by two blinded observers unaware of the analyzed group.
Table 1
Sciatic function index (SFI) 4, 8 and 12 weeks after surgery in experimental groups.
Rat no. Sham TC Chitosan
Weeks
4 8 12 4 8 12 4 8 12
Rat 1 6.4 3.7 4.6 97.4 92.1 95.3 84.3 68.4 49.7
Rat 2 6.1 2.1 5.1 96.7 93.3 96.4 85.4 67.5 48.7
Rat 3 5.9 3.9 4.5 98.1 94.4 95.8 86.1 68.3 50.1
Rat 4 6.8 2.6 5.5 96.4 91.9 93.6 85.8 69.7 48.9
Rat 5 6.1 3.8 4.9 97.1 94.1 94.7 85.3 68.9 49.3
(Mean  SD) 6  0.8 3  0.7 5  0.8 95.12  2.4 93  3.6 94  2.8 85.3  1.59 68.5  2.21 49.3  1.46
Rat no. Vit E PQQ Vit E þ PQQ
Weeks
4 8 12 4 8 12 4 8 12
Rat 1 70.5 56.5 36.7 74.8 59.6 43.4 66.4 51.8 30.3
Rat 2 71.4 57.3 37.5 75.6 60.5 44.5 67.7 52.8 31.6
Rat 3 70.7 58.7 38.6 73.5 61.4 45.3 66.5 54.6 32.7
Rat 4 71.6 55.8 38.3 75.5 58.6 45.9 67.6 51.5 32.5
Rat 5 70.5 56.8 37.6 74.4 59.6 44.5 66.5 52.3 31.5
(Mean  SD) 70.4  1.35 56.9  2.20 37.3  1.19 74.3  1.59 59.3  2.21 44.2  1.46 66.4  1.30 51.9  3.31 31.3  1.19
Fig. 1. Percentage recovery of conduction velocity in treatment groups. Data are pre-
sented as mean  SD. *P < 0.005 vs chitosan group. **P < 0.005 vs PQQ group.
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Graft middle cable of Sham, TC, Chit and treatment groups were
harvested and ﬁxed with glutaraldehyde 2.5%. The grafts were then
embedded in paraplast parafﬁn, cut in 5 mm and were stained with
methylene blue next. Morphometric analysis was carried out using
an image analyzing software (Image-Pro Express, version 6.0.0.319,
Media Cybernetics, Silver Springs, MD, USA). Equal opportunity,
systematic random sampling and two-dimensional dissector rules
were followed in order to cope with sampling-related, ﬁber-loca-
tion-related and ﬁber-size-related biases.30
2.8. Immunohistochemical analysis observation
Anti-S-100 (1:200, DAKO)was used asmarker formyelin sheath.
Specimens prior to immunohistochemistry were post ﬁxed with 4%
paraformaldehyde for two hours and embedded in parafﬁn. After
non-speciﬁc immunoreactions were blocked, sections were incu-
bated in S-100 protein antibody solution for one hour at room
temperature. They were washed three times with PBS and incu-
bated in biotynilated anti-mouse rabbit IgG solution for one hour.
Horseradish peroxidase-labeled secondary antibody was devel-
oped by the diaminobenzidine method. The results of immuno-
histochemistry were examined under a light microscope.
2.9. Statistical analysis
Experimental results were expressed as means  SD. All data
were analyzed by one-way analysis of variance (ANOVA) to assess
statistical signiﬁcance between experimental groups (SPSS 17.0 for
Windows). Dunnett’s test for pair wise comparisons was used to
examine the effect of time and treatments. The differences were
considered signiﬁcant when P < 0.05.
3. Results
3.1. Recovery of sciatic nerve function
The results of SFI values are presented in Table 1. Prior to sur-
gery, SFI values in all groups were near zero. After the nerve tran-
section, the mean SFI decreased to100 due to the complete loss of
sciatic nerve function in all animals. At the end of the study, the
animals of treatment groups achieved a signiﬁcant better meanvalue for SFI compared to that of control group. The statistical an-
alyses revealed that the recovery of nerve functionwas signiﬁcantly
(P < 0.05) different between chit group and treatment groups. The
functional recovery signiﬁcantly accelerated with application of Vit
E, PQQ and their combination in the course of time. Also, this
improvement was better with Vit E-PQQ combination compared to
Vit E or PQQ solely.
3.2. Electrophysiology
Fig. 1 shows the mean percentage of conduction velocity of the
regenerated nerves at the end of experiment. The mean conduction
velocity along the regenerated sciatic nerves with application of Vit
E, PQQ and Vit E-PQQ combinationwere 42% CVR, 34% CVR and 54%
CVR of the intact right side, respectively. These were signiﬁcantly
higher than chit group which was 17% CVR (p < 0.001). This value
were signiﬁcantly better for groups with application of Vit E
(p < 0.028) and Vit E-PQQ combination (p < 0.016) in comparison
with PQQ only.
The mean recovery indices for the regenerated sciatic nerves
with application of Vit E, PQQ and Vit E-PQQ combination were
0.482, 0.312 and 0.5 of the intact right side, respectively. Thesewere
signiﬁcantly higher than chit group which was 0.148 (p < 0.001)
(Fig. 2). Also, this value were signiﬁcantly better for groups with
application of Vit E (p < 0.033) and Vit E-PQQ combination
(p < 0.019) in comparison with PQQ only. These ﬁndings revealed
Fig. 2. Recovery index in treatment groups. Data are presented as mean  SD.
*P < 0.005 vs Chitosan group. **P < 0.005 vs PQQ group.
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ORIGINAL RESEARCHbetter motor functional recovery of the regenerated nerves in using
of Vit E-PQQ combination.
3.3. Muscle mass
Following electrophysiological recordings, all animals were
sacriﬁced for weighting the gastrocnemius muscle and histological
and morphometrical analysis. The mean ratios of gastrocnemius
muscle weight were measured at the end of the study period (12
weeks after surgery). There was a statistically signiﬁcant difference
of the muscle weight ratios among the treatments and Chit groups
(P < 0.05). The muscle weight ratios in Vit E, PQQ and Vit E-PQQ
combination groups were larger than in Chit group, this value was
signiﬁcantly better for group with application of Vit E-PQQ com-
bination in comparisonwith Vit E and PQQ; and also is better for Vit
E group in comparison with PQQ group. Otherwise, weight loss in
gastrocnemius muscle was ameliorated by those topical treatments
(Fig. 3).
3.4. Histological and morphometric ﬁndings
Table 2 shows the quantitative morphometric analyses of the
regenerated nerves for each of the experimental groups. The
treatment groups presented signiﬁcantly greater nerve ﬁber, axon
diameter, and myelin sheath thickness 4, 8 and 12 weeks after
surgery, compared to Chit group (P < 0.05). On the whole, the
histologic and morphometric ﬁndings showed Vit E-PQQ combi-
nation had more effects on the nerve regeneration than the rest of
treatment groups.Fig. 3. Gastrocnemius muscle weight measurement. The gastrocnemius muscles of
both sides (injured left and uninjured right) were removed and weighed in the
treatment groups at 12 weeks after surgery. Values are given as mean  SD. *P < 0.005
vs Chitosan group. **p < 0.005 vs Vit E and PQQ. ***P < 0.005 vs PQQ. Ta
b
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ORIGINAL RESEARCH3.5. Immunohistochemistry
Immunoreactivity to S-100 protein was extensively observed in
the cross sections of the regenerated nerve segments. The expres-
sion of S-100 protein signal was located mainly in the myelin
sheath. The axon also showed a weak expression indicating that
Schwann cell-like phenotype existed around the myelinated axons
(Fig. 4). The ﬁndings and the expression of S-100 resembled those
of the histological evaluations.
4. Discussion
In the present study, the beneﬁcial effects of topically adminis-
trated Vit E, PQQ and their combination were shown through
functional, electrophysiological, morphometrical and immunohis-
tochemical ﬁndings in a rat transection sciatic nerve model.Fig. 4. Immunohistochemical analysis of the regenerated nerves 12 weeks after surgery from
more positive staining of the myelin sheath-associated protein S-100 (arrows) within the pe
treated nerve compared to that of the SIL group. Scale bar: 10 mm.Reconstruction of extensive peripheral nerve defects usually needs
nerve bridging using conduit or nerve graft techniques. Various
organic or synthetic materials have been used as conduit for
studying of axonal regeneration in experimentalmodels. Nowadays,
conduits are mainlymade of non-bioabsorbable materials including
silicone or bioabsorbable materials such as aliphatic polyesters,
polyurethane, collagen, chitosan and excised artery or vein.2,5,6,31e33
Reportedly, chitosan is a biocompatible and timely biodegrad-
able product which have hemostatic and bacteriostatic properties
and low toxicity beside low cost.10,34e37 Chitosan stimulates the
tissue repair process and favors angiogenesis.38 It’s degraded
products are nontoxic, nonimmunogenic and noncarcinogenic.39
Also, Schwann cells have capacity to adhere and survive on chito-
san substratum.40,41
Therefore, these beneﬁcial characteristics convinced us to use
this type of conduit for bridging of the experimentally sciatic nervemiddle cable (A) Sham, (B) TC, (C) VitE/PQQ (D) CHIT, (E) PQQ, (F) Vit E. There is clearly
riphery of nerve, indicating well organized structural nerve reconstruction in VitE/PQQ
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ORIGINAL RESEARCHgap in present study. Furthermore, the worthwhile capacity of the
home-made chitosan conduit was considered in a previous exper-
imental study.11
Topical administration of Vit E, PQQ and their combination
improved functional recovery of the regenerated sciatic nerve. The
results showed, animals of the treatment groups achieved a sig-
niﬁcant better mean value for SFI compared to Chit group. The
highest improvement was identiﬁed for Vit E-PQQ combination
which may suggest a synergism effect.
The greater gastrocnemius muscle weight in the treatment
groups than Chit group indicated indirect evidence of successful
end organ reinnervation in the treated animals. The gastrocnemius
muscle weight loss was well ameliorated by topical application of
Vit E-PQQ similar to the functional recovery results.
The beneﬁcial effects of topical application of Vit E-PQQ com-
bination and each one were shown by higher mean conduction
velocity records along the regenerated sciatic nerves. In this regard,
Vit E-PQQ combination was more advantageous than Vit E and the
latter was more effective than PQQ. Furthermore, the mean re-
covery indices for the regenerated sciatic nerves with application of
Vit E-PQQ combination, Vit E and PQQ were higher than control
group. In this regard, Vit E-PQQ combination and Vit E were
more effective than PQQ. In general, these ﬁndings suggested the
beneﬁcial synergistic effect of motor functional recovery of the
regenerated nerves with topical application using of Vit E-PQQ
combination.
In general, the quantitative morphometrical indices showed
signiﬁcant improvement of the regenerated nerve ﬁbers in treated
animals within the study period. As other assessments, topical
application of Vit E-PQQ combinationwasmore effective than other
treatments indicating its beneﬁcial synergistic effects on the nerve
regeneration.
In immunohistochemistry, the location of reactions to S-100
in treatment groups were clearly more positive than control
group further implying that those regenerated axon and
Schwann cell-like cells existed and were accompanied by the
process of myelination and the structural recovery of regenerated
nerve ﬁbers.
The exact mechanism of Vit E and PQQ in enhancement of nerve
regeneration is not clear. In the present study, local application of
Vit E, PQQ, and Vit E-PQQ combination enhanced sciatic nerve
regeneration. Lack of vitamin E in rat diet, potentially contributes to
an increase in free radicals. The number of free radicals has also
been found to increase as a result of surgical procedures. Report-
edly, the axon myelination could deteriorate due to an increase in
free radicals and a decrease in antioxidants.22 Otherwise, a reduc-
tion of nerve regeneration, size and density of myelinated axons in
Vit E-deﬁcit rats is reported.42
Vitamin E as a lipophilic antioxidant protects cell membrane
against lipid peroxidation chain reactions,43e45 and strengthens
protection against nerve dysfunction caused by oxidative stress.46
Reportedly, Schwann cell growth is greatly stimulated by PQQ.
This cell promoter as well as oxidative scavenger could reduce
nerve damage by oxidizing the redox modulatory site of N methyl
D-aspartate (NMDA) receptors. Nmethyl D-aspartate receptor has a
close relationship with peripheral nerve injuries, which induce
NMDA- or glutamate-mediated cell injuries by polysynaptic path-
ways.47 PQQ can enhance NGF synthesis48 from target tissues and
Schwann cells.23,49 and this neurotrophic factor demonstrate a
signiﬁcant capacity for improving peripheral nerve regeneration
after injury.50,51 It seems local administration of PQQ may also
enhance NGF synthesis which contributes to accelerated nerve
regeneration.
Maturation and Schwann cells migration into the bridging
tube by some neurotrophic factors are essential for the growth ofregenerating myelinated axons. As a result of neurotrophic
stimulation or contact with a regenerating neurite axolemma,
Schwann cells send out cytoplasmic processes that envelope un-
myelinated axons. These facilitate axonal nourishment, growth and
myelination.47
Signiﬁcant improvement and acceleration of peripheral nerve
regeneration by local administration of Vit E and PQQ into chitosan
conduit may result from microenvironment facilities, inﬂuence the
growth and regenerative capacity of injured neurons.
5. Conclusion
The present study demonstrated that local application of Vit E-
PQQ combination accelerate and improve peripheral nerve regen-
eration after transection of sciatic nerve in rat. These antioxidants
are readily available and their topical applications are easily per-
formed without limitations of their probably poor bioavailability in
systemic and oral administration.
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